Exploratory analysis identifies potential antigen targets in inflammatory myopathies, suggesting avenues for immunotherapy.
In the anti-Mi2 subgroup, we identified novel HLA alleles, amino-acid variants, and immunogenic epitopes, supporting a role for HLA-restricted antigen presentation in disease pathogenesis and indicating candidate targets for antigen-specific immunotherapy. However, the HLA/epitope findings related to anti-Mi2 are exploratory due to limited power, and require confirmation in larger cohorts together with experimental validation.
No takes yet. Share an insight, caveat, or question.
Jassal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: